Overview
Status
Active
Registry date
2016-05-09
Share capital
200,000.00 PLN
Registered address
ul. Chełmska 6/8/64, 00-725 Warszawa, Poland
Electronic delivery address
AE:PL-93181-65090-SFBTB-24
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 62 days for 2024).
- 2025not filed
- 202415/09/2025
- 202303/07/2024
- 202211/07/2023
- 202105/09/2022
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 545.33kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -7.22kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 550.72kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 101.54kMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Łukasz Estkowski – President of the Management Board
Marcin Gawryś – Management Board Member
Manner of representation
Each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Łukasz Estkowskiage 48 | 2,000 | $27,012.43 | 50% |
Marcin Gawryśage 51 | 2,000 | $27,012.43 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-08-06.
25 1090 2590 0000 0001 3321 3915
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $17,487.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,248$1,248 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 10, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,231$9,231 | Polski Fundusz Rozwoju S.A. | |
| Jun 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,248$1,248 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cosmedicasp. z o.o. | $49,355,260.75 | cosmedica.pl | ||
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-03-14 | Address change (Ul. Chełmska 6/8/6, 00-725, Warszawa → Ul. Chełmska 6/8/64, 00-725, Warszawa) | |
| 2017-01-09 | Share capital increase (5,000.00 PLN → 200,000.00 PLN) | |
| 2016-05-09 | Entered in the register |
FAQ
The main business activity of Apteki Familijne focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on May 9, 2016.
The headquarters is located at: ul. Chełmska 6/8, 00-725 Warszawa.
The share capital of the company is PLN 200,000 (approx. $54,025).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $545,325, representing an increase of 8.5% compared to 2023.
No, in 2024 the company reported a net loss of $7,224.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $407,670 in 2024, representing 74% of all operating expenses.
Last updated: 2026-04-17